Synapsoft logo
AI Insights from Disclosures
Searching...
QuantaMatrix Incorporated 317690
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
QuantaMatrix Incorporated engages in the research and development, production, and sale of in vitro diagnostics (IVD) medical devices that use samples collected from inside the human body, such as blood, feces, body fluids, and saliva, for the purpose of disease prevention and diagnosis, prognosis prediction, and assessment of health status and treatment efficacy, targeting tertiary general hospitals and testing agencies in Korea and abroad. The IVD market is classified into eight sub-markets by test type, including immunochemistry, self blood glucose monitoring, molecular diagnostics, and clinical microbiology diagnostics, and the company, based mainly on its microbial diagnostic technology, is focused on developing IVD devices for antimicrobial susceptibility testing of sepsis and bacteremia, and on commercializing medical devices for the early diagnosis and prognosis prediction of various diseases based on its own molecular immunodiagnostic testing platform.
Representative Director 권성훈, 홍영석 (공동대표이사)
Founded November 29, 2010
Corporation Type KOSDAQ
Industry Classification Manufacture of other medical and surgical equipment and orthopedic appliances n.e.c.
Corporate number 11011-4481274
Business number 119-86-35864
Phone Number 02-6956-3458
Fax Number 02-763-8650
Company Address 131 Gasan digital 1-ro, Geumcheon-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant